“…The main stakeholder group studied was pharmacists (n = 27, 42%), including those registered as prescribers [22,26,29,63,67,80], nonprescribers [23, 24, 30, 32, 44-48, 51, 55, 56, 73, 74], or mixed prescribers and nonprescribers [19,20,37,58,60,66,70]. Fewer studies investigated the perceptions of patients (n = 12, 19%) [18,25,27,31,34,36,38,52,54,64,68,71], doctors (n = 6, 9%) [21,40,42,61,75,82], the general public (n = 4, 6%) [28,33,49,57], nurses (n = 1, 2%) [43] or policymakers (n = 1, 2%) [76]. Fourteen studies reported multiple stakeholder perspectives [35,39,41,50 While most studies (n = 41, 63%) provided a standardized or legislative definition of pharmacist prescribing, 24 (37%) did not [19, 21, 25, 30, 31, 36-38, 40-43, 46, 49, 50, 52-54, 57, 73, 77-80].…”